The Foundation supports research that will lead to the creation of better Parkinson's treatments. Here are some of the patient-relevant projects the Foundation has recently funded.
If you are looking for a specific project, please search our Funded Grants Database.
Elisa Greggio, PhD
Institution: University of Padova
MJFF Program: Understanding LRRK2 Biology 2009
Mark Cookson, PhD
Institution: National Institute on Aging, National Institutes of Health
MJFF Program: Understanding LRRK2 Biology 2009
Veerle Baekelandt, PhD
Institution: Katholieke Universiteit Leuven
MJFF Program: Understanding LRRK2 Biology 2009
Jean Marc Taymans, PhD/Ir
Institution: Laboratory of Neurobiology and Gene Therapy, KULeuven
MJFF Program: Understanding LRRK2 Biology 2009
Luigi Bubacco, PhD
Institution: Department of Biology, University of Padova
MJFF Program: Understanding LRRK2 Biology 2009
Shu G. Chen, PhD
Institution: Case Western Reserve University School of Medicine
MJFF Program: Understanding LRRK2 Biology 2009
Amy L. Wilson-Delfosse, PhD
Institution: Case Western Reserve University School of Medicine
MJFF Program: Understanding LRRK2 Biology 2009
Steven Riddle
Institution: Life Technologies (Invitrogen)
MJFF Program: Understanding LRRK2 Biology 2009
Kurt W. Vogel, PhD
Institution: Life Technologies (Invitrogen)
MJFF Program: Understanding LRRK2 Biology 2009
John Dunlop, PhD
Institution: Pfizer Global R&D, Neuroscience Research Unit
MJFF Program: Understanding LRRK2 Biology 2009
Zhenyu Yue, PhD
Institution: Mt. Sinai School of Medicine
MJFF Program: Understanding LRRK2 Biology 2009
David S. Park, PhD
Institution: University of Ottawa
MJFF Program: Understanding LRRK2 Biology 2009
Jie Shen, PhD
Institution: Harvard Medical School
MJFF Program: Understanding LRRK2 Biology 2009
Michael Schlossmacher, MD
Institution: Ottawa Hospital Research Institute
MJFF Program: Understanding LRRK2 Biology 2009
